CJASN (@cjasn) 's Twitter Profile
CJASN

@cjasn

The leading voice for the latest advancements in clinical nephrology. Official publication of @ASNKidney. Impact Factor 9.8.

ID: 2773651974

linkhttp://cjasn.asnjournals.org/ calendar_today27-08-2014 16:02:37

3,3K Tweet

28,28K Followers

1,1K Following

CJASN (@cjasn) 's Twitter Profile Photo
CJASN
@cjasn

a year ago

Clinical trials have demonstrated remarkable benefits of SGLT-2 inhibitors. This collection from JASN_News, CJASN, & ASN Kidney360 highlights rapidly advancing knowledge of SGLT-2 inhibitor benefits, risks, mechanisms of action, and applications bit.ly/ASNSGLT2 #jnlcoll

Clinical trials have demonstrated remarkable benefits of SGLT-2 inhibitors. This collection from <a href="/JASN_News/">JASN_News</a>, CJASN, &amp; <a href="/ASNKidney360/">ASN Kidney360</a> highlights rapidly advancing knowledge of SGLT-2 inhibitor benefits, risks, mechanisms of action, and applications bit.ly/ASNSGLT2 #jnlcoll